FDA Finds Possible Risk Of Guillain-Barre Syndrome With Pfizer’s RSV Vaccine For Older Adults

CNBC (2/24, Kimball) reported the FDA “sees a possible risk of Guillain-Barre syndrome with Pfizer’s RSV vaccine for older adults and has asked the company to conduct a safety study if the shot is approved this spring, according to agency briefing documen...